Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Myeloproliferative Neoplasm, BCR-ABL1 Negative — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Morphology
Hematopoietic and Lymphoid Cell Neoplasm
Myeloid Neoplasm
Myeloproliferative Neoplasm
Myeloproliferative Neoplasm, BCR-ABL1 Negative

Molecular Subtype

Myeloproliferative Neoplasm, BCR-ABL1 Negative

CI-CAN-00003386Explore in graph →

Hematologic94 active trials2 approved drugs8 evidence items

NCIt: C198555

Overview
Statistics
Survival
Genomics
Variants & evidence8
Drugs3
Trials333
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

333 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 94
Recruiting: 50
Ph III recruiting: 7
Growth YoY: —
Industry share: 41%
Top sponsor: City of Hope Medical Center
Termination share: 35.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (56)

StatusAll Active (any)Completed 147 Recruiting 60 Active Not Recruiting 41 Terminated 41 Withdrawn 16 Unknown 14 Not Yet Recruiting 9 Available 2 No Longer Available 2 Suspended 1

PhaseAll Early Phase 1 5 N/A 30 Phase 1 97 Phase 2 141 Phase 3 40 Phase 4 3

No study matches these filters